{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:26:27Z","timestamp":1783455987928,"version":"3.55.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["16\u201301781S"],"award-info":[{"award-number":["16\u201301781S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["19\u201301747S"],"award-info":[{"award-number":["19\u201301747S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["AZV\u2013NU20\u201304\u20130136"],"award-info":[{"award-number":["AZV\u2013NU20\u201304\u20130136"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["8F19004"],"award-info":[{"award-number":["8F19004"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["Q27\/LF1"],"award-info":[{"award-number":["Q27\/LF1"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Cognitive decline is a key characteristic of Huntington\u2019s disease (HD). This study aimed to investigate the diagnostic accuracy of a cognitive battery with six tests used by most HD research centers to assess cognitive impairment in HD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>In total, 106 HD patients in different disease stages with more (HD-CD, N\u00a0=\u00a030) and less cognitive impairments (HD-NC, N\u00a0=\u00a070) and 100 healthy controls (NC) were matched by age, sex, and education and were examined using a standardized protocol including cognitive, motor, and functional assessments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One-way between-groups analysis of variance showed that controls performed significantly better than HD patients and that HD-NC significantly outperformed HD-CD patients in all cognitive tests (NC\u00a0&amp;gt;\u00a0HD-NC\u00a0&amp;gt;\u00a0HD-CD), with all Games-Howell post-hoc tests p\u00a0&amp;lt;\u00a0.001. Analyses using area under the receiver-operating characteristic curve (AUC) disclosed the diagnostic accuracy of all tests included in the battery to discriminate between NC and HD patients with AUC ranging from 0.809 to 0.862 (all p\u00a0&amp;lt;\u00a0.001) and between HD-CD and HD-NC patients with AUC ranging from 0.833 to 0.899 (all p\u00a0&amp;lt;\u00a0.001). In both analysis, Stroop Color Naming Test showed the highest discriminative potential. Additional analyses showed that cognitive deficits in all domains progressed with disease duration. Moreover, cognitive performance correlated with the severity of motor and functional impairment (all p\u00a0&amp;lt;\u00a0.001) and with the Disease Burden Score regardless of disease duration and age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our results indicate that the cognitive battery is a suitable tool for assessing cognitive impairment in HD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/arclin\/acaa038","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T11:15:52Z","timestamp":1592738152000},"page":"74-86","source":"Crossref","is-referenced-by-count":3,"title":["Validation Study of a German Cognitive Battery for Huntington\u2019s Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden"],"prefix":"10.1093","volume":"36","author":[{"given":"Al\u017ebeta","family":"M\u00fchlb\u00e4ck","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, Huntington Center South, kbo-Isar-Amper-Klinikum, Taufkirchen (Vils), Germany"},{"name":"Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"},{"name":"Department of Neurology, University Hospital of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Klemp\u00ed\u0159ov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Bezd\u00ed\u010dek","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Huntington Center South, kbo-Isar-Amper-Klinikum, Taufkirchen (Vils), Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hofstetter","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Pain Therapy, Day Clinic, Klinikum Erding, Erding, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Bernhard","family":"Landwehrmeyer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Klemp\u00ed\u0159","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"issue":"1","key":"2021011505343253400_ref1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annual Review of Neuroscience"},{"issue":"4","key":"2021011505343253400_ref2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nature Genetics"},{"key":"2021011505343253400_ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cortex.2017.07.017","article-title":"Cognitive decline in Huntington\u2019s disease expansion gene carriers","volume":"95","author":"Baake","year":"2017","journal-title":"Cortex"},{"issue":"8","key":"2021011505343253400_ref4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.56.8.1052","article-title":"Retest effects and cognitive decline in longitudinal follow-up of patients with early HD","volume":"56","author":"Bachoud L\u00e9vi","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"2021011505343253400_ref5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/13803390903313564","article-title":"Cognitive change in patients with Huntington disease on the repeatable battery for the assessment of neuropsychological status","volume":"32","author":"Beglinger","year":"2010","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"9","key":"2021011505343253400_ref6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.25101","article-title":"Clinical predictors of driving status in Huntington\u2019s disease","volume":"27","author":"Beglinger","year":"2012","journal-title":"Movement Disorders"},{"key":"2021011505343253400_ref7","volume-title":"Multilingual aphasia examination","author":"Benton","year":"1989"},{"key":"2021011505343253400_ref8","volume-title":"Contributions to neuropsychological assessment: A clinical manual","author":"Benton","year":"1994","edition":"2nd"},{"issue":"1","key":"2021011505343253400_ref9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09084282.2012.670158","article-title":"Validity of the Montreal cognitive assessment in the detection of cognitive dysfunction in Huntington\u2019s disease","volume":"20","author":"Bezdicek","year":"2013","journal-title":"Applied Neuropsychology"},{"issue":"2","key":"2021011505343253400_ref10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.31887\/DCNS.2007.9.2\/rbonelli","article-title":"Frontal-subcortical circuitry and behavior","volume":"9","author":"Bonelli","year":"2007","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"2021011505343253400_ref11","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988","edition":"2nd"},{"issue":"3","key":"2021011505343253400_ref12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/13803390902926184","article-title":"Cognitive deficits in Huntington\u2019s disease on the repeatable battery for the assessment of neuropsychological status","volume":"32","author":"Duff","year":"2010","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"2","key":"2021011505343253400_ref13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.870100213","article-title":"Functional decline in Huntington\u2019s disease","volume":"10","author":"Feigin","year":"1995","journal-title":"Movement Disorders"},{"issue":"3","key":"2021011505343253400_ref14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"2021011505343253400_ref15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/23273798.2014.918630","article-title":"Proficiency and control in verbal fluency performance across the lifespan for monolinguals and bilinguals","volume":"30","author":"Friesen","year":"2015","journal-title":"Language, Cognition and Neuroscience"},{"key":"2021011505343253400_ref16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2012.10.001","article-title":"Automated differentiation of pre-diagnosis Huntington\u2019s disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: The IMAGE-HD study","volume":"51","author":"Georgiou-Karistianis","year":"2013","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"2021011505343253400_ref17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","article-title":"Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms","volume":"1","author":"Giralt","year":"2012","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"2","key":"2021011505343253400_ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0920-9964(95)00069-0","article-title":"Subcortical dysfunction in schizophrenia: a comparison with Parkinson\u2019s disease and Huntington\u2019s disease","volume":"19","author":"Hanes","year":"1996","journal-title":"Schizophrenia Research"},{"issue":"2","key":"2021011505343253400_ref19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/0894-4105.19.2.243","article-title":"A meta-analytic review of verbal fluency deficits in Huntington\u2019s disease","volume":"19","author":"Henry","year":"2005","journal-title":"Neuropsychology"},{"issue":"6","key":"2021011505343253400_ref20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.acn.2003.09.003","article-title":"A meta-analysis of the sensitivity and specificity of the Stroop color and word test with children","volume":"19","author":"Homack","year":"2004","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"2","key":"2021011505343253400_ref21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: reliability and consistency","volume":"11","author":"HSG","year":"1996","journal-title":"Movement Disorders"},{"issue":"6","key":"2021011505343253400_ref22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"Huntington\u2019s disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"issue":"18","key":"2021011505343253400_ref23","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1523\/JNEUROSCI.3147-12.2013","article-title":"Revisiting the functional specialization of left inferior frontal Gyrus in phonological and semantic fluency: the crucial role of task demands and individual ability","volume":"33","author":"Katzev","year":"2013","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"2021011505343253400_ref24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/13854049408404136","article-title":"Evaluation of the reliability and validity of the repeatable cognitive-perceptual-motor battery","volume":"8","author":"Kelland","year":"1994","journal-title":"The Clinical Neuropsychologist"},{"issue":"6","key":"2021011505343253400_ref25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.69.6.773","article-title":"Subtle changes among presymptomatic carriers of the Huntington\u2019s disease gene","volume":"69","author":"Kirkwood","year":"2000","journal-title":"Neurosurgery & Psychiatry"},{"issue":"4","key":"2021011505343253400_ref26","first-page":"217","article-title":"Unified Huntington\u2019s disease rating scale: clinical practice and a critical approach","volume":"21","author":"Klemp\u00ed\u0159","year":"2006","journal-title":"Functional Neurology"},{"issue":"10","key":"2021011505343253400_ref27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00415-009-5164-9","article-title":"The relationship between impairment of voluntary movements and cognitive impairment in Huntington\u2019s disease","volume":"256","author":"Klemp\u00ed\u0159","year":"2009","journal-title":"Journal of Neurology"},{"issue":"2","key":"2021011505343253400_ref28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mdc3.12388","article-title":"Data analytics from Enroll-HD, a global clinical research platform for Huntington\u2019s disease","volume":"4","author":"Landwehrmeyer","year":"2017","journal-title":"Movement Disorders Clinical Practice"},{"issue":"3","key":"2021011505343253400_ref29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1355617715000090","article-title":"Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington\u2019s disease gene-expansion carriers","volume":"21","author":"Larsen","year":"2015","journal-title":"Journal of the International Neuropsychological Society"},{"key":"2021011505343253400_ref30","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mneumonic functions in early Huntington\u2019 s disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"key":"2021011505343253400_ref31","volume-title":"Neuropsychological assessment","author":"Lezak","year":"2012","edition":"5th"},{"issue":"3","key":"2021011505343253400_ref32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mds.25657","article-title":"Tracking motor impairments in the progression of Huntington\u2019s disease","volume":"29","author":"Long","year":"2014","journal-title":"Movement Disorders"},{"issue":"2","key":"2021011505343253400_ref33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mds.27227","article-title":"Rating scales for cognition in Huntington\u2019s disease: Critique and recommendations","volume":"33","author":"Mestre","year":"2018","journal-title":"Movement Disorders"},{"issue":"9","key":"2021011505343253400_ref34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part I. clinical and neuropsychological assessment of Alzheimer\u2019s disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"issue":"1","key":"2021011505343253400_ref35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","article-title":"Smaller intracranial volume in prodromal Huntington\u2019s disease: evidence for abnormal neurodevelopment","volume":"134","author":"Nopoulos","year":"2011","journal-title":"Brain"},{"issue":"5","key":"2021011505343253400_ref36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","article-title":"Cognitive impairment in Huntington disease: diagnosis and treatment","volume":"11","author":"Paulsen","year":"2011","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"11","key":"2021011505343253400_ref37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/mds.25997","article-title":"Onset of Huntington\u2019s disease: can it be purely cognitive?","volume":"29","author":"Paulsen","year":"2014","journal-title":"Movement Disorders"},{"issue":"12","key":"2021011505343253400_ref38","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington\u2019s disease with clinical and imaging measures: a prospective observational study","volume":"13","author":"Paulsen","year":"2014","journal-title":"Lancet Neurology"},{"key":"2021011505343253400_ref39","first-page":"69","volume-title":"Handbook of Clinical Neurology","author":"Paulsen","year":"2017"},{"issue":"11","key":"2021011505343253400_ref40","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp-2013-305114","article-title":"Cognitive decline in prodromal Huntington disease: implications for clinical trials","volume":"84","author":"Paulsen","year":"2013","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"2021011505343253400_ref41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","article-title":"Cognitive and functional decline in Huntington\u2019s disease: dementia criteria revisited","volume":"25","author":"Peavy","year":"2010","journal-title":"Movement Disorders"},{"issue":"5","key":"2021011505343253400_ref42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in huntington\u2019s disease","volume":"41","author":"Penney","year":"1997","journal-title":"Annals of Neurology"},{"issue":"3","key":"2021011505343253400_ref43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/nmt.13.18","article-title":"Managing juvenile Huntington\u2019s disease","volume":"3","author":"Quarrell","year":"2013","journal-title":"Neurodegenerative Disease Management"},{"issue":"5","key":"2021011505343253400_ref44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/mds.21920","article-title":"Patient and caregiver quality of life in Huntington\u2019s disease","volume":"23","author":"Ready","year":"2008","journal-title":"Movement Disorders"},{"issue":"3","key":"2021011505343253400_ref45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Perceptual and Motor Skills"},{"key":"2021011505343253400_ref46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JHD-190350","article-title":"Cognitive screening tests in Huntington gene mutation carriers: examining the validity of the mini-mental state examination and the Montreal cognitive assessment","volume":"9","author":"Ringk\u00f8bing","year":"2020","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"1","key":"2021011505343253400_ref47","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"11","key":"2021011505343253400_ref48","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26012","article-title":"Determinants of functional disability in Huntington\u2019s disease: role of cognitive and motor dysfunction","volume":"29","author":"Ross","year":"2014","journal-title":"Movement Disorders"},{"issue":"11","key":"2021011505343253400_ref49","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/jnnp.57.11.1389","article-title":"Initial letter and semantic category fluency in Alzheimer\u2019s disease, Huntington\u2019s disease, and progressive supranuclear palsy","volume":"57","author":"Rosser","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"2021011505343253400_ref50","first-page":"1","volume-title":"Advances in anatomy, embryology, and cell biology","author":"R\u00fcb","year":"2015"},{"key":"2021011505343253400_ref51","first-page":"1","article-title":"Widespread increased diffusivity reveals early cortical degeneration in Huntington disease","author":"Sampedro","year":"2019","journal-title":"American Journal of Neuroradiology"},{"issue":"3","key":"2021011505343253400_ref52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1017\/S1355617709090626","article-title":"Construct validity of the trail making test: role of task-switching, working memory, inhibition\/interference control, and visuomotor abilities","volume":"15","author":"S\u00e1nchez-Cubillo","year":"2009","journal-title":"Journal of the International Neuropsychological Society"},{"issue":"772","key":"2021011505343253400_ref53","article-title":"What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults","volume":"5","author":"Shao","year":"2014","journal-title":"Frontiers in Psychology"},{"key":"2021011505343253400_ref54","volume-title":"Symbol digit modalities test (SDMT) manual (revised)","author":"Smith","year":"1982"},{"key":"2021011505343253400_ref55","first-page":"379","article-title":"Symbol digit modalities test (SDMT)","author":"Smith","year":"1991","journal-title":"Neuropsychological Assessment"},{"issue":"7","key":"2021011505343253400_ref56","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/arclin\/acx086","article-title":"The neuropsychology of Huntington\u2019s disease","volume":"32","author":"Snowden","year":"2017","journal-title":"Archives of Clinical Neuropsychology"},{"key":"2021011505343253400_ref57","doi-asserted-by":"crossref","DOI":"10.1017\/S1355617701711046","article-title":"Longitudinal evaluation of cognitive disorder in Huntington\u2019s disease","author":"Snowden","year":"2001","journal-title":"Journal of the International Neuropsychological Society"},{"issue":"1","key":"2021011505343253400_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"issue":"10","key":"2021011505343253400_ref59","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/mds.25964","article-title":"HD-CAB: a cognitive assessment battery for clinical trials in Huntington\u2019s disease","volume":"29","author":"Stout","year":"2014","journal-title":"Movement Disorders"},{"issue":"6","key":"2021011505343253400_ref60","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"Journal of Experimental Psychology"},{"issue":"1","key":"2021011505343253400_ref61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropsychologia.2009.09.002","article-title":"Automaticity and attention in Huntington\u2019s disease: When two hands are not better than one","volume":"48","author":"Thompson","year":"2010","journal-title":"Neuropsychologia"},{"key":"2021011505343253400_ref62","doi-asserted-by":"crossref","DOI":"10.1186\/2047-9158-3-15","article-title":"Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington\u2019s disease: a 12-month longitudinal study","volume":"3","author":"Toh","year":"2014","journal-title":"Translational Neurodegeneration"},{"issue":"5192","key":"2021011505343253400_ref63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/222437a0","article-title":"The Stroop test: selective attention to colours and words","volume":"222","author":"Treisman","year":"1969","journal-title":"Nature"},{"issue":"3","key":"2021011505343253400_ref64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.10718","article-title":"Objective assessment of motor slowness in Huntington\u2019s disease: clinical correlates and 2-year follow-up","volume":"19","author":"Vugt","year":"2004","journal-title":"Movement Disorders"},{"issue":"3","key":"2021011505343253400_ref65","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential Therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiological Reviews"}],"container-title":["Archives of Clinical Neuropsychology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/acn\/article-pdf\/36\/1\/74\/35858190\/acaa038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/acn\/article-pdf\/36\/1\/74\/35858190\/acaa038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T10:34:49Z","timestamp":1610706889000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/acn\/article\/36\/1\/74\/5865566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2021,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/arclin\/acaa038","relation":{},"ISSN":["1873-5843"],"issn-type":[{"value":"1873-5843","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2]]},"published":{"date-parts":[[2020,7,1]]}}}